Sort
15,273 grants matching “antimicrobial resistance”
Prevention of oxidative stress decreases persistence of drug tolerant M. Tubercu
$211,884Randall J Basaraba · Colorado State University · R21 · FY2009 · AI
Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients
$211,875Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Discovery of antibiotics active against multidrug resistant bacteria
$211,875Roberto G. Kolter · Harvard Medical School · R21 · FY2016 · AI
Investigating the relationship between antibiotics and nosocomial pneumonia.
$211,875Victor J Torres · New York University School Of Medicine · R21 · FY2021 · AI
Determination of the mode of action of the antibiotic pyrazinamide
$211,875Alexandre Gouzy · Weill Medical Coll Of Cornell Univ · R21 · FY2023 · AI
âProtection from MRSA lethality by inhibiting LXRα phosphorylationâ
$211,875Michael J Garabedian · New York University School Of Medicine · R21 · FY2024 · AI
Role of Pin-domain toxins in Mycobacterium tuberculosis pathogenesis
$211,750James Scott Butler · University Of Rochester · R21 · FY2009 · AI
Low Temperature Plasma as an Approach for the Treatment of Peri-Implantitis
$211,716Simone Duarte · Indiana University Indianapolis · R21 · FY2019 · DE
Genomic evidences based novel therapy for Staphylococcal infections
$211,613Ashok Kumar · Wayne State University · R21 · FY2019 · AI
IL-22 in HBV pathogenesis
$211,508Michael D Robek · Yale University · R21 · FY2009 · CA
Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery
$211,454Chengcang Charles Wu · Intact Genomics, Inc. · R43 · FY2015 · AI
Bifunctional Control of Yop Translocation by YopK
$211,451Melanie Marketon · Tufts University Boston · R01 · FY2015 · AI
Novel Dental Adhesives to Prevent Recurrent Caries
$211,441Walter G. Renne · Cure Innovations, Llc · R41 · FY2016 · DE
MODELS FOR TESTING CANDIDATE TOPICAL MICROBICIDES FOR CYTOTOXICITY AND ACTIVITY A
$211,420Mary F Lampe · University Of Washington · R21 · FY2007 · AI
Biology of Infectious Diseases Training Program
$211,335Henry F Chambers · University Of California, San Francisco · T32 · FY2014 · AI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections
$211,331Huizhou Fan · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2007 · AI
STRUCTURAL STUDIES OF BACTERIAL HYALURONATE LYASE ENZYME
$211,287Children'S Hospital &Res Ctr At Oakland · R01 · FY2003 · AI
Administrative Core
$211,127Myron Max Levine · University Of Maryland Baltimore · U19 · FY2023 · AI
Training in Pediatric Infectious Diseases
$211,121Lisa Saiman · Columbia University Health Sciences · T32 · FY2016 · AI
Synthetic tools for new antibiotics
$211,052William P Malachowski · Bryn Mawr College · R15 · FY2010 · GM
Activation of Insect Immunity by Gram-Negative Bacteria
$211,048Neal Silverman · Univ Of Massachusetts Med Sch Worcester · R56 · FY2017 · AI
Horizontal Genetic Transfer In Staphylococci
$211,027Ashley Robinson · New York Medical College · R01 · FY2008 · GM
Mechanistic Characterization of CRISPR-Cas Complexes that Mediate Pathogenicity in the Bacterium Francisella tularensis novicida (Rajan)
$211,004Rakhi Rajan · University Of Oklahoma · P20 · FY2018 · GM
Mechanistic Characterization of CRISPR-Cas Complexes that Mediate Pathogenicity in the Bacterium Francisella tularensis novicida (Rajan)
$211,004Rakhi Rajan · University Of Oklahoma · P20 · FY2019 · GM
Phage-Based Therapeutics for Ocular Infections
$210,975Michelle C Callegan · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2021 · EY